ResearcherSir Run Run Shaw HospitalActive in the last 2 years
Chaolei Zhang
Matched on OpenAlex author ID A5132541599. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 7
- Filgotinib inhibits METTL3-mediated m6A of EIF3A by targeting ERG-TBP to suppress PDAC progression JAK-STAT3-independently. Co-author DOI 10.1038/s41698-026-01396-z↗
- Targeted delivery of the PKMYT1 inhibitor RP-6306 mediates PANoptosis in pancreatic cancer via mitotic catastrophe. Co-author DOI 10.1038/s41419-025-07835-2↗
- Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. First author DOI 10.1016/j.tranon.2023.101847↗
- Discovery of an 8-oxoguanine regulator PCBP1 inhibitor by virtual screening and its synergistic effects with ROS-modulating agents in pancreatic cancer. Co-author DOI 10.3389/fmolb.2024.1441550↗
- Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex. Co-author DOI 10.1016/j.bbagrm.2023.194941↗
- ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.01.013↗
- VRK2 activates TNFα/NF-κB signaling by phosphorylating IKKβ in pancreatic cancer. Co-author DOI 10.7150/ijbs.66313↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Liping Cao · 6 shared papers, 2022–2025 · strength 1.21
- Paper Targeted delivery of the PKMYT1 inhibitor RP-6306 mediates PANoptosis in pancreatic cancer via mitotic catastrophe. DOI 10.1038/s41419-025-07835-2↗
- Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847↗
- Paper Discovery of an 8-oxoguanine regulator PCBP1 inhibitor by virtual screening and its synergistic effects with ROS-modula… DOI 10.3389/fmolb.2024.1441550↗
- Shengnan Jia · 4 shared papers, 2023–2026 · strength 0.92
- Paper Filgotinib inhibits METTL3-mediated m6A of EIF3A by targeting ERG-TBP to suppress PDAC progression JAK-STAT3-independen… DOI 10.1038/s41698-026-01396-z↗
- Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847↗
- Paper Discovery of an 8-oxoguanine regulator PCBP1 inhibitor by virtual screening and its synergistic effects with ROS-modula… DOI 10.3389/fmolb.2024.1441550↗
- Xiaofan Pu · 3 shared papers, 2023–2026 · strength 0.70
- Paper Filgotinib inhibits METTL3-mediated m6A of EIF3A by targeting ERG-TBP to suppress PDAC progression JAK-STAT3-independen… DOI 10.1038/s41698-026-01396-z↗
- Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847↗
- Paper Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via d… DOI 10.1016/j.bbagrm.2023.194941↗
- Kexiong Qiao · 3 shared papers, 2022–2026 · strength 0.69
- Paper Filgotinib inhibits METTL3-mediated m6A of EIF3A by targeting ERG-TBP to suppress PDAC progression JAK-STAT3-independen… DOI 10.1038/s41698-026-01396-z↗
- Paper Discovery of an 8-oxoguanine regulator PCBP1 inhibitor by virtual screening and its synergistic effects with ROS-modula… DOI 10.3389/fmolb.2024.1441550↗
- Paper VRK2 activates TNFα/NF-κB signaling by phosphorylating IKKβ in pancreatic cancer. DOI 10.7150/ijbs.66313↗
- Liangjing Zhou · 3 shared papers, 2022–2026 · strength 0.67
- Paper Filgotinib inhibits METTL3-mediated m6A of EIF3A by targeting ERG-TBP to suppress PDAC progression JAK-STAT3-independen… DOI 10.1038/s41698-026-01396-z↗
- Paper Discovery of an 8-oxoguanine regulator PCBP1 inhibitor by virtual screening and its synergistic effects with ROS-modula… DOI 10.3389/fmolb.2024.1441550↗
- Paper ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response … DOI 10.1016/j.canlet.2022.01.013↗
- Chaojie Huang · 2 shared papers, 2022–2025 · strength 0.42
- Paper Targeted delivery of the PKMYT1 inhibitor RP-6306 mediates PANoptosis in pancreatic cancer via mitotic catastrophe. DOI 10.1038/s41419-025-07835-2↗
- Paper ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response … DOI 10.1016/j.canlet.2022.01.013↗
- Tianshu Pang · 2 shared papers, 2022–2024 · strength 0.37
- Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847↗
- Paper ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response … DOI 10.1016/j.canlet.2022.01.013↗
- Jingyun Chen · 1 shared paper, 2025 · strength 0.27
- Tao Shen · 1 shared paper, 2024 · strength 0.22
- Dongnan Ping · 1 shared paper, 2023 · strength 0.18
- Jionghuang Chen · 1 shared paper, 2022 · strength 0.17
- Guoping Ding · 1 shared paper, 2022 · strength 0.15
- Shengnan Jia · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.